Economic benefit of anti-endotoxin therapy in veterinary practice.
D000818:Animals; D001424:Bacterial Infections / Q000628:therapy / Q000662:veterinary*; D007136:Immunoglobulins; D008070:Lipopolysaccharides / Q000276:immunology* / Q000627:therapeutic use
D007136:Immunoglobulins; D008070:Lipopolysaccharides; C042866:antilipopolysaccharide antibodies